Safety and tolerability of atopaxar (E5555) in acute coronary syndromes: The LANCELOT-ACS trial

Michelle O'Donoghue, David J. Moliterno

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety and tolerability of atopaxar (E5555) in acute coronary syndromes: The LANCELOT-ACS trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science